- CMTA Unveils Updated LogoThe CMTA’s new logo, which we are revealing for the first time in the Spring 2019 issue of The CMTA Report, is only the third version in our 35-year history.Read more ...
- 2019 Spring CMTA ReportClinical Trials: A Primer! In addition to our regular features, read about “A Clinical Trial for Caroline,” fast tracking and more.Read more ...
- A Cure for Caroline and Other CMT StoriesCaroline’s journey with a rare and serious form of CMT began when she was just 9 months old. Today, a cure for Caroline may open the door to treatments and a cure for CMT!Read more ...
- Type 1 CMT Gene Therapy Project Now UnderwayMutations in the gene coding for the gap junction beta-1 protein (GJB1), also known as connexin 32 (Cx32), are associated with CMT1X. Dr. Kleopa will test whether delivery of the Cx32 gene using an adeno-associated virus (AAV) vector can improve ...Read more ...
- CMTA-Funded Research Database Identifies New MutationsWhile researchers have identified more than 90 mutated genes that cause CMT, approximately 50 percent of CMT2 patients do not yet have a definitive genetic diagnosis. Dr. Stephan Züchner at the University of Miami is working to change that.Read more ...